PriceTargets.com logo

kneat.com - KSI Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: C$3.70
  • Forecasted Upside: -12.94%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
C$4.25 As of 11/12/2021 09:48 PM ET
▲ +0.19 (4.68%)

This chart shows the closing price for KSI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New kneat.com Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for KSI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for KSI

Analyst Price Target is C$3.70
▼ -12.94% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for kneat.com in the last 3 months. The average price target is C$3.70, with a high forecast of C$3.70 and a low forecast of C$3.70. The average price target represents a -12.94% upside from the last price of C$4.25.

This chart shows the closing price for KSI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in kneat.com. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/5/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/3/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/1/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/2/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/31/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/29/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/28/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/27/2023

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/26/2022Raymond JamesSet TargetOutperformC$3.70
11/11/2021Echelon Wealth PartnersReiterated RatingSpeculative Buy
4/29/2021Eight CapitalBoost TargetC$4.25 ➝ C$4.50
3/29/2021Eight CapitalSet TargetBuyC$4.25
6/12/2020CormarkBoost TargetC$2.50 ➝ C$2.75
3/13/2020CormarkLower TargetBuyC$2.50 ➝ C$2.35
1/9/2019Echelon Wealth PartnersReiterated RatingSpeculative Buy
(Data available from 1/27/2018 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/30/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/30/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/29/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/28/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/28/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/27/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/27/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/26/2023

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
kneat.com logo
kneat.com, inc. designs, develops, and supplies software for data and document management within regulated environments in the United States, Ireland, Canada, internationally. The company offers Kneat Gx platform, a configurable commercial off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. Its platform is used in instrument, method, utility and facility, process, equipment, computer system, cold chain, and cleaning validation, as well commissioning and qualification, and electronic logbook management. It also provides software-related services, including training, installation, upgradation, consulting, and maintenance, as well as process mapping, project management, and other services. The company is headquartered in Limerick, Ireland.
Read More

Today's Range

Now: C$4.25
Low: C$4.10
High: C$4.30

50 Day Range

MA: C$4.25
Low: C$4.25
High: C$4.25

52 Week Range

Now: C$4.25
Low: C$2.00
High: C$4.85

Volume

114,330 shs

Average Volume

42,978 shs

Market Capitalization

C$325.27 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of kneat.com?

The following equities research analysts have issued stock ratings on kneat.com in the last twelve months: Raymond James.
View the latest analyst ratings for KSI.

What is the current price target for kneat.com?

1 Wall Street analysts have set twelve-month price targets for kneat.com in the last year. Their average twelve-month price target is C$3.70, suggesting a possible downside of 12.9%. Raymond James has the highest price target set, predicting KSI will reach C$3.70 in the next twelve months. Raymond James has the lowest price target set, forecasting a price of C$3.70 for kneat.com in the next year.
View the latest price targets for KSI.

What is the current consensus analyst rating for kneat.com?

kneat.com currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe KSI will outperform the market and that investors should add to their positions of kneat.com.
View the latest ratings for KSI.

What other companies compete with kneat.com?

Other companies that are similar to kneat.com include Dialogue Health Technologies, WELL Health Technologies, ProMetic Life Sciences, HLS Therapeutics and Fennec Pharmaceuticals. Learn More about companies similar to kneat.com.

How do I contact kneat.com's investor relations team?

The company's listed phone number is 353 6 120 3826. The official website for kneat.com is www.kneat.com. Learn More about contacing kneat.com investor relations.